The long-term study on a pool of older PCa men (avg age = 70) was published today in JAMA and found:
Among 154,000 older patients, 13% who received hormone-blocking treatment developed Alzheimer’s, compared with 9% who had other treatment or chose no therapy, the study found.
.
.
The risk for dementia from strokes or other causes was higher: It was diagnosed in 22% of those who got hormone-blocking treatment, versus 16% of the other patients.
It is possible that the conduit from ADT to dementia may be the blood vessel damage caused by diabetes, or heart disease or depression.
https://www.apnews.com/f1412c26dc4c43189099e3165b9901f5